Publications by authors named "Martin Holst"

Claim this Profile
T
Trials that turn from retrospectively registered to prospectively registered: a cohort study of "retroactively prospective" clinical trial registration using history data.
Martin Holst, Benjamin Gregory Carlisle

Trials· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of multiple changes to prespecified primary outcomes of clinical trials completed between 2009 and 2017 in German university medical centers: A meta-research study.
Martin Holst, Martin Haslberger, Samruddhi Yerunkar, Daniel Strech, Lars G Hemkens

PLoS Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finding the best fit for improving reproducibility: reflections from the QUEST Center for Responsible Research.
Natascha Drude, Lorena Martinez-Gamboa, Tamarinde Haven, Constance Holman, Martin Holst

BMC Res Notes· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stakeholders' views on an institutional dashboard with metrics for responsible research.
Tamarinde L Haven, Martin R Holst, Daniel Strech

PLoS One· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results dissemination from completed clinical trials conducted at German university medical centers remained delayed and incomplete. The 2014 -2017 cohort.
Nico Riedel, Susanne Wieschowski, Till Bruckner, Martin R Holst, Hannes Kahrass

J Clin Epidemiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapy.
Michael Ehrhardt, Rogerio B Craveiro, Martin I Holst, Torsten Pietsch, Dagmar Dilloo

Oncotarget· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In comparative analysis of multi-kinase inhibitors for targeted medulloblastoma therapy pazopanib exhibits promising in vitro and in vivo efficacy.
Rogerio B Craveiro, Michael Ehrhardt, Martin I Holst, Thorsten Pietsch, Dagmar Dilloo

Oncotarget· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioral changes in G72/G30 transgenic mice.
David M Otte, Andras Bilkei-Gorzó, Michaela D Filiou, Christoph W Turck, Oznur Yilmaz, Martin Ingo Holst

Eur Neuropsychopharmacol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engrailed-2 regulates genes related to vesicle formation and transport in cerebellar Purkinje cells.
Martin I Holst, Christian Maercker, Bogdan Pintea, Marco Masseroli, Christian Liebig

Mol Cell Neurosci· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental expression and differentiation-related neuron-specific splicing of metastasis suppressor 1 (Mtss1) in normal and transformed cerebellar cells.
Alexander Glassmann, Sabine Molly, Lachezar Surchev, Tommy A Nazwar, Martin Holst

BMC Dev Biol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetraspanin-5 (Tm4sf9) mRNA expression parallels neuronal maturation in the cerebellum of normal and L7En-2 transgenic mice.
Hendrik Juenger, Martin I Holst, Katja Duffe, Jakob Jankowski, Stephan L Baader

J Comp Neurol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engrailed-2 negatively regulates the onset of perinatal Purkinje cell differentiation.
Jakob Jankowski, Martin I Holst, Christian Liebig, John Oberdick, Stephan L Baader

J Comp Neurol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis